People are searching for IRBBB primarily because of a collision between modern technology and scary-sounding medical terminology. More people are getting routine Electrocardiograms (ECGs) than ever before—whether through
Conduit selection in Coronary Artery Bypass Grafting (CABG) remains a critical factor in determining long-term graft patency, patient survival, and the need for repeat revascularization. The choice involves
Coronary steal is a brilliant concept to break down visually, as it perfectly illustrates the limits of microvascular autoregulation and explains the seemingly paradoxical effects of certain cardiac
Non-HDL cholesterol (Non-HDL-C) is not directly measured; it is derived from a simple calculation, subtracting high-density lipoprotein cholesterol (HDL-C) from total cholesterol (TC): Non-HDL-C = TC – HDL-C
Cardiac Magnetic Resonance (CMR) has established itself as the non-invasive gold standard for myocardial tissue characterization. In ischemic heart disease (IHD), its utility extends far beyond simple ejection
The management of congenital complete heart block (CCHB) has evolved from a reactive approach to one that emphasizes prenatal risk stratification, pharmacological prevention, and long-term pacing strategies designed
Rotational atherectomy (RA), commonly known as rotablation, is a percutaneous coronary intervention (PCI) technique used to modify heavily calcified coronary lesions prior to balloon angioplasty and stent placement.
The medical management of Non-ST-Elevation Myocardial Infarction (NSTEMI) hinges on rapid risk stratification, optimal antithrombotic therapy, and determining the appropriate timing for an invasive strategy. The current approach,
The newer generation of anticoagulants—commonly referred to as Direct Oral Anticoagulants (DOACs) or Non-Vitamin K Antagonist Oral Anticoagulants (NOACs)—have largely replaced Vitamin K antagonists like warfarin for most
Lipoprotein(a)—commonly abbreviated as Lp(a)—has evolved from being viewed as a mere marker of residual cardiovascular risk to a recognized, independent, and causal driver of coronary artery disease (CAD)
